Loading...
Integer Holdings Corporation
ITGR•NYSE
Healthcare
Medical - Devices
$108.51
$1.41(1.32%)
Integer Holdings Corporation (ITGR) Financial Performance & Income Statement Overview
Review Integer Holdings Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
7.51%
↑ 7.51%
Operating Income Growth
24.45%
↑ 24.45%
Net Income Growth
32.26%
↑ 32.26%
Operating Cash Flow Growth
13.87%
↑ 13.87%
Operating Margin
12.48%
↑ 12.48%
Gross Margin
26.90%
↑ 26.90%
Net Profit Margin
4.61%
↑ 4.61%
ROE
5.05%
↑ 5.05%
ROIC
7.10%
↑ 7.10%
Integer Holdings Corporation (ITGR) Income Statement & Financial Overview
Review Integer Holdings Corporation's (ITGR) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $437.39M | $449.50M | $431.42M | $436.57M |
| Cost of Revenue | $317.07M | $332.70M | $314.85M | $324.04M |
| Gross Profit | $120.32M | $116.80M | $116.57M | $112.53M |
| Gross Profit Ratio | $0.28 | $0.26 | $0.27 | $0.26 |
| R&D Expenses | $14.20M | $10.61M | $11.92M | $16.10M |
| SG&A Expenses | $38.89M | $47.47M | $33.85M | $37.13M |
| Operating Expenses | $70.77M | $59.76M | $58.56M | $51.83M |
| Total Costs & Expenses | $387.84M | $392.46M | $373.41M | $375.87M |
| Interest Income | -$95000.00 | $1.50M | $0.00 | $0.00 |
| Interest Expense | $14.80M | $12.14M | $14.58M | $14.34M |
| Depreciation & Amortization | $29.83M | $28.93M | $28.69M | $27.23M |
| EBITDA | $30.90M | $80.32M | $86.69M | $84.47M |
| EBITDA Ratio | $0.07 | $0.18 | $0.20 | $0.19 |
| Operating Income | $49.55M | $57.03M | $58.01M | $60.70M |
| Operating Income Ratio | $0.11 | $0.13 | $0.13 | $0.14 |
| Other Income/Expenses (Net) | -$62.55M | -$17.77M | -$14.59M | -$15.16M |
| Income Before Tax | -$13.00M | $39.26M | $43.42M | $40.03M |
| Income Before Tax Ratio | -$0.03 | $0.09 | $0.10 | $0.09 |
| Income Tax Expense | $9.47M | $6.29M | $7.14M | $8.78M |
| Net Income | -$22.49M | $32.70M | $35.44M | $31.25M |
| Net Income Ratio | -$0.05 | $0.07 | $0.08 | $0.07 |
| EPS | -$0.66 | $0.97 | $1.05 | $0.93 |
| Diluted EPS | -$0.66 | $0.90 | $0.99 | $0.88 |
| Weighted Avg Shares Outstanding | $33.92M | $33.66M | $33.66M | $33.60M |
| Weighted Avg Shares Outstanding (Diluted) | $33.92M | $36.24M | $35.79M | $35.53M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan